Clinical Trial Update: Assessment of Mucosal Activity to Improve the Prognosis of Patients With Crohn's Disease Treated With Immunosuppressants [Phase 3]

View source ↗

Summary

A Phase 3 trial assessing mucosal activity to improve prognosis in Crohn's disease patients treated with immunosuppressants has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Crohn Disease

Drugs mentioned

• Immunosuppressants

Snippet

Sponsor: Grupo Espanol de Trabajo en Enfermedad de Crohn y Colitis Ulcerosa | Conditions: Crohn's Disease, Mucosal Inflammation | Phase 3 | Status: TERMINATED